APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sialylated Human Milk Oligosaccharides (HMO)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sialylated Human Milk Oligosaccharides (HMO) Market Analysis and Forecast 2026-2032

4 July 2026194 pages

Choose your research edition.

Industry ResearchSialylated Human Milk Oligosaccharides (HMO) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Sialylated Human Milk Oligosaccharides (HMO) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Sialylated Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sialylated Human Milk Oligosaccharides (HMO) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Sialylated Human Milk Oligosaccharides (HMO) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Sialylated Human Milk Oligosaccharides (HMO) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Sialylated Human Milk Oligosaccharides (HMO) include Chr. Hansen (Jennewein Biotechnologie GmgH), DSM (Glycom A/S), Inbiose, Kyowa Hakko Bio, GeneChem Inc. and FrieslandCampina Ingredients, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sialylated Human Milk Oligosaccharides (HMO), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sialylated Human Milk Oligosaccharides (HMO), also provides the sales of main regions and countries. Of the upcoming market potential for Sialylated Human Milk Oligosaccharides (HMO), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sialylated Human Milk Oligosaccharides (HMO) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sialylated Human Milk Oligosaccharides (HMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sialylated Human Milk Oligosaccharides (HMO) sales, projected growth trends, production technology, application and end-user industry.

Sialylated Human Milk Oligosaccharides (HMO) Segment by Company

Chr. Hansen (Jennewein Biotechnologie GmgH)

DSM (Glycom A/S)

Inbiose

Kyowa Hakko Bio

GeneChem Inc.

FrieslandCampina Ingredients

Sialylated Human Milk Oligosaccharides (HMO) Segment by Type

3'-Sialyllactose

6'-Sialyllactose

Sialylated Human Milk Oligosaccharides (HMO) Segment by Application

Infant Formula

Food

Others

Sialylated Human Milk Oligosaccharides (HMO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sialylated Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sialylated Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sialylated Human Milk Oligosaccharides (HMO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Sialylated Human Milk Oligosaccharides (HMO) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Sialylated Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sialylated Human Milk Oligosaccharides (HMO) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 3'-Sialyllactose Major Manufacturers Table 3. 6'-Sialyllactose Major Manufacturers Table 4. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Infant Formula Major Manufacturers Table 6. Food Major Manufacturers Table 7. Others Major Manufacturers Table 8. Sialylated Human Milk Oligosaccharides (HMO) Industry Trends Table 9. Sialylated Human Milk Oligosaccharides (HMO) Industry Drivers Table 10. Sialylated Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges Table 11. Sialylated Human Milk Oligosaccharides (HMO) Industry Restraints Table 12. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2026) Table 16. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2027-2032) Table 17. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 18. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026) & (t) Table 19. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2027-2032) & (t) Table 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2026) Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2027-2032) Table 22. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Price (USD/t) of Manufacturers (2021-2026) Table 27. Global Sialylated Human Milk Oligosaccharides (HMO) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Sialylated Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application Table 30. Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Sialylated Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2026) Table 37. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2027-2032) Table 38. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type 2021 VS 2025 VS 2032 (t) Table 39. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (t) Table 40. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (t) Table 41. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2026) Table 42. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2027-2032) Table 43. Global Sialylated Human Milk Oligosaccharides (HMO) Price by Type (2021-2026) & (USD/t) Table 44. Global Sialylated Human Milk Oligosaccharides (HMO) Price by Type (2027-2032) & (USD/t) Table 45. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2026) Table 49. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2027-2032) Table 50. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application 2021 VS 2025 VS 2032 (t) Table 51. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (t) Table 52. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (t) Table 53. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2026) Table 54. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2027-2032) Table 55. Global Sialylated Human Milk Oligosaccharides (HMO) Price by Application (2021-2026) & (USD/t) Table 56. Global Sialylated Human Milk Oligosaccharides (HMO) Price by Application (2027-2032) & (USD/t) Table 57. Chr. Hansen (Jennewein Biotechnologie GmgH) Company Information Table 58. Chr. Hansen (Jennewein Biotechnologie GmgH) Business Overview Table 59. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 60. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 61. Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Development Table 62. DSM (Glycom A/S) Company Information Table 63. DSM (Glycom A/S) Business Overview Table 64. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 65. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 66. DSM (Glycom A/S) Recent Development Table 67. Inbiose Company Information Table 68. Inbiose Business Overview Table 69. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 70. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 71. Inbiose Recent Development Table 72. Kyowa Hakko Bio Company Information Table 73. Kyowa Hakko Bio Business Overview Table 74. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 76. Kyowa Hakko Bio Recent Development Table 77. GeneChem Inc. Company Information Table 78. GeneChem Inc. Business Overview Table 79. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 81. GeneChem Inc. Recent Development Table 82. FrieslandCampina Ingredients Company Information Table 83. FrieslandCampina Ingredients Business Overview Table 84. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio Table 86. FrieslandCampina Ingredients Recent Development Table 87. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (t) Table 90. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (t) Table 91. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2021-2026) & (USD/t) Table 92. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2027-2032) & (USD/t) Table 93. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (t) Table 96. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (t) Table 97. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2021-2026) & (USD/t) Table 98. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2027-2032) & (USD/t) Table 99. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021 VS 2025 VS 2032) & (t) Table 103. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (t) Table 104. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (t) Table 105. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Country (2021-2026) & (USD/t) Table 106. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Country (2027-2032) & (USD/t) Table 107. United States Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 108. Canada Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 109. Mexico Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 110. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (t) Table 113. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (t) Table 114. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2021-2026) & (USD/t) Table 115. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2027-2032) & (USD/t) Table 116. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (t) Table 119. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (t) Table 120. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2021-2026) & (USD/t) Table 121. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2027-2032) & (USD/t) Table 122. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021 VS 2025 VS 2032) & (t) Table 126. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (t) Table 127. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (t) Table 128. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Country (2021-2026) & (USD/t) Table 129. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Country (2027-2032) & (USD/t) Table 130. Germany Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 131. France Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 132. U.K. Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 133. Italy Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 134. Russia Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 135. Spain Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 138. Sweden Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 139. Poland Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 140. China Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & (US$ Million) Table 141. China Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2027-2032) & (US$ Million) Table 142. China Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (t) Table 143. China Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (t) Table 144. China Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2021-2026) & (USD/t) Table 145. China Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2027-2032) & (USD/t) Table 146. China Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & (US$ Million) Table 147. China Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2027-2032) & (US$ Million) Table 148. China Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (t) Table 149. China Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (t) Table 150. China Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2021-2026) & (USD/t) Table 151. China Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2027-2032) & (USD/t) Table 152. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (t) Table 155. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (t) Table 156. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2021-2026) & (USD/t) Table 157. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2027-2032) & (USD/t) Table 158. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (t) Table 161. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (t) Table 162. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2021-2026) & (USD/t) Table 163. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2027-2032) & (USD/t) Table 164. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021 VS 2025 VS 2032) & (t) Table 168. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (t) Table 169. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (t) Table 170. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Country (2021-2026) & (USD/t) Table 171. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Country (2027-2032) & (USD/t) Table 172. Japan Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 173. South Korea Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 174. India Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 175. Australia Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2026) & (t) Table 181. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2027-2032) & (t) Table 182. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2021-2026) & (USD/t) Table 183. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Type (2027-2032) & (USD/t) Table 184. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2026) & (t) Table 187. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2027-2032) & (t) Table 188. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2021-2026) & (USD/t) Table 189. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Application (2027-2032) & (USD/t) Table 190. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021 VS 2025 VS 2032) & (t) Table 194. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021-2026) & (t) Table 195. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2027-2032) & (t) Table 196. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Country (2021-2026) & (USD/t) Table 197. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Country (2027-2032) & (USD/t) Table 198. Brazil Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 199. Argentina Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 200. Chile Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 201. Colombia Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 202. Peru Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 204. Israel Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 205. UAE Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 206. Turkey Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 207. Iran Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 208. Egypt Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Sialylated Human Milk Oligosaccharides (HMO) Distributors List Table 212. Sialylated Human Milk Oligosaccharides (HMO) Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Sialylated Human Milk Oligosaccharides (HMO) Image Figure 2. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 3'-Sialyllactose Image Figure 5. 6'-Sialyllactose Image Figure 6. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Infant Formula Image Figure 9. Food Image Figure 10. Others Image Figure 11. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (2021-2032) & (US$ Million) Figure 13. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2032) Figure 16. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (2021-2032) & (t) Figure 17. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 18. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Sialylated Human Milk Oligosaccharides (HMO) Sales YoY (2021-2032) & (t) Figure 20. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales YoY (2021-2032) & (t) Figure 21. China Sialylated Human Milk Oligosaccharides (HMO) Sales YoY (2021-2032) & (t) Figure 22. Asia (Excluding China) Sialylated Human Milk Oligosaccharides (HMO) Sales YoY (2021-2032) & (t) Figure 23. South America, Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales YoY (2021-2032) & (t) Figure 24. Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2032) Figure 30. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 31. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2032) Figure 33. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2032) Figure 36. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 37. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2032) Figure 39. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Type (2021-2032) Figure 40. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Type (2021-2032) Figure 41. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Application (2021-2032) Figure 42. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Application (2021-2032) Figure 43. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country (2021-2032) Figure 44. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Country (2021-2032) Figure 45. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Type (2021-2032) Figure 46. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Type (2021-2032) Figure 47. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Application (2021-2032) Figure 48. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Application (2021-2032) Figure 49. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country (2021-2032) Figure 50. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Country (2021-2032) Figure 51. China Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Type (2021-2032) Figure 52. China Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Type (2021-2032) Figure 53. China Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Application (2021-2032) Figure 54. China Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Application (2021-2032) Figure 55. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Type (2021-2032) Figure 56. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Type (2021-2032) Figure 57. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Application (2021-2032) Figure 58. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Application (2021-2032) Figure 59. Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country (2021-2032) Figure 60. Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Country (2021-2032) Figure 61. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Type (2021-2032) Figure 62. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Type (2021-2032) Figure 63. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Application (2021-2032) Figure 64. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Application (2021-2032) Figure 65. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Country (2021-2032) Figure 66. SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Country (2021-2032) Figure 67. Sialylated Human Milk Oligosaccharides (HMO) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Sialylated Human Milk Oligosaccharides (HMO) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 3'-Sialyllactose
  • 6'-Sialyllactose
Applications
  • Infant Formula
  • Food
  • Others
Companies covered
  • Chr. Hansen (Jennewein Biotechnologie GmgH)
  • DSM (Glycom A/S)
  • Inbiose
  • Kyowa Hakko Bio
  • GeneChem Inc.
  • FrieslandCampina Ingredients

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sialylated Human Milk Oligosaccharides (HMO) Market by Type
  3. 1.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 3'-Sialyllactose
  5. 1.2.3 6'-Sialyllactose
  6. 1.3 Sialylated Human Milk Oligosaccharides (HMO) Market by Application
  7. 1.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Infant Formula
  9. 1.3.3 Food
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Sialylated Human Milk Oligosaccharides (HMO) Market Dynamics
  1. 2.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Trends
  2. 2.2 Sialylated Human Milk Oligosaccharides (HMO) Industry Drivers
  3. 2.3 Sialylated Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
  4. 2.4 Sialylated Human Milk Oligosaccharides (HMO) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region
  3. 3.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2021-2026)
  5. 3.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2027-2032)
  6. 3.2.4 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region
  9. 3.4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2021-2026)
  11. 3.4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2027-2032)
  12. 3.4.4 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Manufacturers
  2. 4.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Manufacturers
  6. 4.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Sialylated Human Milk Oligosaccharides (HMO) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Sialylated Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
  13. 4.7 Global Sialylated Human Milk Oligosaccharides (HMO) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market CR5 and HHI
  16. 4.8.2 2025 Sialylated Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier 3
5 Sialylated Human Milk Oligosaccharides (HMO) Market by Type
  1. 5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type
  2. 5.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type
  6. 5.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032) & (t)
  8. 5.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Sialylated Human Milk Oligosaccharides (HMO) Price by Type
6 Sialylated Human Milk Oligosaccharides (HMO) Market by Application
  1. 6.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application
  2. 6.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application
  6. 6.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032) & (t)
  8. 6.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Sialylated Human Milk Oligosaccharides (HMO) Price by Application
7 Company Profiles
  1. 7.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
  2. 7.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Company Information
  3. 7.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Business Overview
  4. 7.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  6. 7.1.5 Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments
  7. 7.2 DSM (Glycom A/S)
  8. 7.2.1 DSM (Glycom A/S) Company Information
  9. 7.2.2 DSM (Glycom A/S) Business Overview
  10. 7.2.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  12. 7.2.5 DSM (Glycom A/S) Recent Developments
  13. 7.3 Inbiose
  14. 7.3.1 Inbiose Company Information
  15. 7.3.2 Inbiose Business Overview
  16. 7.3.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  18. 7.3.5 Inbiose Recent Developments
  19. 7.4 Kyowa Hakko Bio
  20. 7.4.1 Kyowa Hakko Bio Company Information
  21. 7.4.2 Kyowa Hakko Bio Business Overview
  22. 7.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  24. 7.4.5 Kyowa Hakko Bio Recent Developments
  25. 7.5 GeneChem Inc.
  26. 7.5.1 GeneChem Inc. Company Information
  27. 7.5.2 GeneChem Inc. Business Overview
  28. 7.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  30. 7.5.5 GeneChem Inc. Recent Developments
  31. 7.6 FrieslandCampina Ingredients
  32. 7.6.1 FrieslandCampina Ingredients Company Information
  33. 7.6.2 FrieslandCampina Ingredients Business Overview
  34. 7.6.3 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
  36. 7.6.5 FrieslandCampina Ingredients Recent Developments
8 North America
  1. 8.1 North America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Type
  2. 8.1.1 North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2032)
  3. 8.1.2 North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032)
  4. 8.1.3 North America Sialylated Human Milk Oligosaccharides (HMO) Price by Type (2021-2032)
  5. 8.2 North America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Application
  6. 8.2.1 North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2032)
  7. 8.2.2 North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032)
  8. 8.2.3 North America Sialylated Human Milk Oligosaccharides (HMO) Price by Application (2021-2032)
  9. 8.3 North America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
  10. 8.3.1 North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Sialylated Human Milk Oligosaccharides (HMO) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Market Size by Type
  2. 9.1.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032)
  4. 9.1.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Price by Type (2021-2032)
  5. 9.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Market Size by Application
  6. 9.2.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032)
  8. 9.2.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Price by Application (2021-2032)
  9. 9.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
  10. 9.3.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Sialylated Human Milk Oligosaccharides (HMO) Market Size by Type
  2. 10.1.1 China Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2032)
  3. 10.1.2 China Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032)
  4. 10.1.3 China Sialylated Human Milk Oligosaccharides (HMO) Price by Type (2021-2032)
  5. 10.2 China Sialylated Human Milk Oligosaccharides (HMO) Market Size by Application
  6. 10.2.1 China Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2032)
  7. 10.2.2 China Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032)
  8. 10.2.3 China Sialylated Human Milk Oligosaccharides (HMO) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sialylated Human Milk Oligosaccharides (HMO) Market Size by Type
  2. 11.1.1 Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032)
  4. 11.1.3 Asia Sialylated Human Milk Oligosaccharides (HMO) Price by Type (2021-2032)
  5. 11.2 Asia Sialylated Human Milk Oligosaccharides (HMO) Market Size by Application
  6. 11.2.1 Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032)
  8. 11.2.3 Asia Sialylated Human Milk Oligosaccharides (HMO) Price by Application (2021-2032)
  9. 11.3 Asia Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
  10. 11.3.1 Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Sialylated Human Milk Oligosaccharides (HMO) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Market Size by Type
  2. 12.1.1 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Price by Type (2021-2032)
  5. 12.2 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Market Size by Application
  6. 12.2.1 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Price by Application (2021-2032)
  9. 12.3 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country
  10. 12.3.1 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Sialylated Human Milk Oligosaccharides (HMO) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Sialylated Human Milk Oligosaccharides (HMO) Value Chain Analysis
  2. 13.1.1 Sialylated Human Milk Oligosaccharides (HMO) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Sialylated Human Milk Oligosaccharides (HMO) Production Mode & Process
  6. 13.2 Sialylated Human Milk Oligosaccharides (HMO) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Sialylated Human Milk Oligosaccharides (HMO) Distributors
  9. 13.2.3 Sialylated Human Milk Oligosaccharides (HMO) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst